pubmed-article:9316969 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C2709248 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0243192 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0001480 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0018549 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0032824 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0599946 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0917866 | lld:lifeskim |
pubmed-article:9316969 | lifeskim:mentions | umls-concept:C0332324 | lld:lifeskim |
pubmed-article:9316969 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:9316969 | pubmed:dateCreated | 1997-10-16 | lld:pubmed |
pubmed-article:9316969 | pubmed:abstractText | Lemakalim, an adenosine triphosphate (ATP)-sensitive potassium (K+(ATP)) channel agonist, causes profound pulmonary vasodilation in conscious dogs, which is attenuated during halothane anesthesia. The goal of the present study was to investigate the mechanism responsible for this attenuating effect of halothane. | lld:pubmed |
pubmed-article:9316969 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:language | eng | lld:pubmed |
pubmed-article:9316969 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9316969 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9316969 | pubmed:month | Sep | lld:pubmed |
pubmed-article:9316969 | pubmed:issn | 0003-3022 | lld:pubmed |
pubmed-article:9316969 | pubmed:author | pubmed-author:MurrayP APA | lld:pubmed |
pubmed-article:9316969 | pubmed:author | pubmed-author:SekiSS | lld:pubmed |
pubmed-article:9316969 | pubmed:author | pubmed-author:HoribeMM | lld:pubmed |
pubmed-article:9316969 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9316969 | pubmed:volume | 87 | lld:pubmed |
pubmed-article:9316969 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9316969 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9316969 | pubmed:pagination | 625-34 | lld:pubmed |
pubmed-article:9316969 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:meshHeading | pubmed-meshheading:9316969-... | lld:pubmed |
pubmed-article:9316969 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9316969 | pubmed:articleTitle | Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist. | lld:pubmed |
pubmed-article:9316969 | pubmed:affiliation | Division of Anesthesiology and Critical Care Medicine, The Cleveland Clinic Foundation, Ohio 44195, USA. | lld:pubmed |
pubmed-article:9316969 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9316969 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:9316969 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |